financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Sell Opinion On Shares Of The Macerich Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Sell Opinion On Shares Of The Macerich Company
May 26, 2025 7:25 AM

02:25 AM EDT, 05/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target price by $2 to $13, 9.4x our 2025 FFO estimate, a discount to peers, reflecting increased property dispositions and elevated leverage (net debt-to-EBITDA was 7.95x). We increase our 2025 FFO estimate by $0.03 to $1.38 and increase 2026's estimate by $0.06 to $1.37. Management provided updates on the Path Forward Plan with $2B in planned dispositions, currently at $1.1 billion (including the Lakewood property under contract). MAC has also identified another $400 million in sale-or-give-back properties over the next two years, with the other dispositions coming from outparcels, freestanding retail, and land. Management believes these property sales and the $400 million equity issuance in Q4 2024 will aid the company in lowering its net debt-to-EBITDA to the mid-6x range by 2026 year-end. We continue to see downside risk in this plan, with management expecting NOI growth from the company's go-forward portfolio to only grow 2%-4% after 2025-2026 sales and stabilization.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Hold Opinion On Shares Of The Toronto-dominion Bank
Research Alert: CFRA Maintains Hold Opinion On Shares Of The Toronto-dominion Bank
May 23, 2024
10:50 AM EDT, 05/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our target price by $1 to $58, 9.7x our FY 2025 (Oct.) EPS view of CAD8.19 (USD5.99), below the peer average P/E of 10.4x to reflect regulatory uncertainty....
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ralph Lauren Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Ralph Lauren Corporation
May 23, 2024
09:35 AM EDT, 05/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $10 to $160, based on 16.0x our FY 25 (Mar.) EPS estimate and slightly higher than the company's five-year average forward P/E multiple...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dupont De Nemours, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dupont De Nemours, Inc.
May 23, 2024
11:25 AM EDT, 05/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price by $10 to $84, valuing DD shares at 24x our '24 EPS estimate of $3.51, versus the one-year average forward multiple of 20x. DD...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Medtronic Plc
Research Alert: CFRA Keeps Buy Opinion On Shares Of Medtronic Plc
May 23, 2024
11:35 AM EDT, 05/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our target by $1 to $97, a 17.8x multiple of our FY 25 EPS forecast, in line with MDT's historical forward average. We narrow our FY 25 EPS...
Copyright 2023-2025 - www.financetom.com All Rights Reserved